Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Nature Communications|June 5, 2019
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutationsRichard W Birkinshaw, Jia-Nan Gong, Cindy S Luo, et al.
Cell Death and Differentiation|March 25, 2022
BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cellsDiane Moujalled, Adam G Southon, Eiman Saleh, et al.
Chemmedchem|March 29, 2014
Simplified silvestrol analogues with potent cytotoxic activityBill C Hawkins, Lisa M Lindqvist, Duong Nhu, et al.
Cell Death & Disease|September 11, 2020
Defining the susceptibility of colorectal cancers to BH3-mimetic compoundsMing-Jie Luo, Michelle Palmieri, Chris D Riffkin, et al.
Journal of Medicinal Chemistry|January 25, 2014
De-novo designed library of benzoylureas as inhibitors of BCL-XL: synthesis, structural and biochemical characterizationRyan M Brady, Amelia Vom, Michael J Roy, et al.
Nature Communications|November 23, 2021
Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosisYanxiang Meng, Katherine A Davies, Cheree Fitzgibbon, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binderRenee N Brown, Rachel Cameron, David K Chalmers, et al.
Nature Chemical Biology|October 9, 2019
A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosisMark F van Delft, Stephane Chappaz, Yelena Khakham, et al.
Nature Microbiology|August 31, 2016
Eliminating Legionella by inhibiting BCL-XL to induce macrophage apoptosisMary Speir, Kate E Lawlor, Stefan P Glaser, et al.
Pageof 12